DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20221475

Some markers of inflammation in patients with sickle cell disease at Zou-Collines departmental hospital in Benin

Houénoukpo Wilfried Hlouedjè, Jacques Ezéchiel Lokonon, Maximin Sènou, Gloria Abissi, Félicienne Agbogba, Espérance Mèdoatinsa, Pascal Tchogou, Blaise Tchékpo, Thierry Marc, Mèdéhouénou ., Eugénie Anago, Casimir Akpovi

Abstract


Background: Sickle cell disease was a genetic pathology of the red blood cell, which caused systemic functional and tissue damage. The present work aimed to study some biomarkers of inflammation and renal function in sickle cell patients.

Methods: The biochemical and inflammatory markers were assayed with a spectrophotometer and the hemogram was performed on a hematology analyzer in SS homozygous sickle cell subjects and controls with AA phenotypes.

Results: The male sex (63.49%) and the age group 5-18 years (58.73%) were predominant among the SS subjects of the study population. Blood urea and serum creatinine were significantly higher in SS, suggesting impaired renal function. Serum uric acid was significantly lower in SS. Aspartate transaminase (AST) was significantly higher in SS and alanine transaminase (ALT) did not change significantly, indicating significant cytolysis. Mean hemoglobin level was significantly lower in SS, signifying more hemolysis. The mean number of blood leukocytes, neutrophils, eosinophilia, lymphocytes and monocytes were significantly higher in SS. There was the same for C-reactive protein, the concentration of which was very high (96 mg/l) in 34.92% of sickle cell patients against 1.75% in AA, indicating an inflammatory state in sickle cell disease. In contrast, the mean number of blood platelets was significantly lower in SS.

Conclusions: During sickle cell disease, there were inflammation, cytolysis and disturbance of renal function as well as anemia. The early evaluation of these biological markers may prevent complications and crises of sickle cell disease.


Keywords


Sickle cell disease, Kidneys, Inflammation, Biomarkers, Benin

Full Text:

PDF

References


Yousafzai SM, Ugurlucan M, Al Radhwan OA, Al Otaibi AL, Canver CC. Open Heart Surgery in Patients With Sickle Cell Hemoglobinopathy. Circulation. 2010;121(1):14‑9.

Cavazzana M, Antoniani C, Miccio A. Gene Therapy for β-Hemoglobinopathies. Mol Ther. 2017;25(5):1142‑54.

Rémy P, Audard V, Galactéros F. Rein et hémoglobinopathies. Néphrologie Thérapeutique. 2016;12(2):117‑29.

Cappelli B, Gluckman E, Ghanem K, Abboud MR. Hemoglobinopathies (Sickle Cell Disease and Thalassemia). In: Carreras E, Dufour C, Mohty M, Kröger N, éditeurs. The EBMT Handbook. Cham: Springer International Publishing. 2020;595‑601.

Lemrabott M, Faye S, Fall MC, Dial MM, Cissé K, Fall ALR, et al. Atteintes rénales au cours des syndromes drépanocytaires majeurs au CHU Aristide Le Dantec (Sénégal). 2018;5:247-438.

Bartolucci P, El Murr T, Roudot-Thoraval F, Habibi A, Santin A, Renaud B, et al. Randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood. 2009;114:3742-7.

Chetcha CB, Ola’a Bamzok EK, Ngo Sack F, Ngouadjeu E, Mbanya D. Morbidity and mortality of sickle cell patients in the Hematology Department of the Yaounde Central Hospital. Health Sci Dis. 2018;19(1).

Elion J, Laurance S, Lapouméroulie C. Physiopathologie de la drépanocytose. Med Trop. 2010;70:454-8.

Garcia NP, Júnior ALS, Soares GAS, Costa TCC, dos Santos APC, Costa AG, et al. Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1 β, IL-12/VEGF, and IL-10/IP-10 Axis. J Immunol Res. 2020:1‑22.

Charrin E, Dubé JJ, Connes P, Pialoux V, Ghosh S, Faes C, et al. Moderate exercise training decreases inflammation in transgenic sickle cell mice. Blood Cells Mol Dis. 2018;69:45‑52.

Carvalho MOS, Araujo-Santos T, Reis JHO, Rocha LC, Cerqueira BAV, Luz NF. Inflammatory mediators in sickle cell anaemia highlight the difference between steady state and crisis in paediatric patients. Br J Haematol. 2018;182(6):933‑6.

Berry PA, JS Croix T, Thein SL, Portmann BC, Wendon JA, Karani JB, et al. Clin Gastroenterol Hepatol. 2007;5(12):1469-76.

Nacoulma E, Sakande J, Kafando E, Kpowbié ED, Guissou IP. Profil hématologique et biochimique des drépanocytaires SS et SC en phase stationnaire au Centre Hospitalier National Yalgado Ouedraogo de Ouagadougou. Mali Medical. 2006;21(1):8-11.

Dahmani F, Benkirane S, Kouzih J, Woumki A, Mamad H, Masrar A. Profil épidémiologique des hémoglobinopathies: étude autour du cas index: étude transversale descriptive. Pan Afr Med J. 2017;27.

Doupa D, Djite M, Gueye PM, Seck M, Faye BF, Seck SM et al. Profil biochimique et hématologique des patients drépanocytaires homozygotes en phase stationnaire au centre National de Transfusion Sanguine de Dakar. Int J Bio Chem Sci. 2017;11:1706.

Diallo DA. Sickle cell disease in africa: current situation and strategies for improving the quality and duration of survival. Science Direct. 2008;192(7):1361-73.

Diagne I, Ndiaye O, Moreira C, Signate–Sy H, Camara B. Les syndromes drépanocytaires majeurs à Dakar (Sénégal). Arch Pédiatr. 2000;7(1):16-24.

Monkaila B, Oumarou HK, Garba M, Maiga A, Akpona SA, Sanogo I. Hémolyse chronique des sujets drépanocytaires SS et SC en phase stationnaire : étude comparative au centre national de référence de la drépanocytose à Niamey. Revue Cames Sante. 2015;3(1):25-9.

Dokékias A, Nzingoula S. Profil du sujet drépanocytaire après l’âge de 30 ans. Médecine d’Afrique Noire, 2001;48(10):411-8.

Shongo MYP, Mukuku O, Mutombo AM, Lubala TK, Ilunga PM, Sombodi WU et al. Profil hématologique et nutritionnel du drépanocytaire homozygote SS âgé de 6 à 59 mois à Lubumbashi, République Démocratique du Congo. Pan Afr Med J. 2015;21.

Mabiala BJR, Nkanza KSAT, Ganza ZPS, Nzingoula S, Senga P. Causes d'hospitalisation des enfants drépanocytaires: influence de l'âge (CHU de Brazzaville, Congo). Bull Soc Pathol Exot. 2005;98(5):392-3.

Chies JA, NardiI NB. Sickle cell disease: a chronic inflammatory condition. Medical Hypoth. 2001;57(1):46- 50.

Sènou M, Agbangnan DCP, Zime N‟Gobi AR, Abissi GY, Agbogba F, Sèzan A, Loko F. In malaria, acute inflammation level depends on parasitaemia. Int J Pharm Biol Sci. 2017;7(2):23-30.

Ateba GN, Ateba MHG. Evaluation of glomerular function of sickle cell patients in Yaounde Health Sci Dis. 2017;18(2).

Garba M, Tondi ZMM, Diongoule H, Aboubacar S, Ide A, Biyao-Nelson NR, et al. Dépistage de la néphropathie dans les syndromes drépanocytaires majeurs chez les patients suivis au Centre national de référence de la drépanocytose de Niamey, Niger. Néphrol Ther. 2018;1027.

Sènou M, Lokonon JE, Agbogba F, Agbangnan DCP, Odoulami S, Tchogou AP, et al. In vitro study of some characteristics of red blood cells with hemoglobin S. Int J Biosci. 2017;10(1):311-7.